Korst, C. L. B. M., Tahri, S., Duetz, C., Bruins, W. S. C., Jonge, A. V. D., Jong, M. E. D., Fokkema, C., Smits, F., Groen, K., Verkleij, C. P. M., Frerichs, K. A., Papazian, N., Duin, M. V., Beek, G. V., Hoogenboezem, R., Baardemans, T., Collo, G. D., Stoetman, E. C. G., Cosovic, M., Twickler, I., Rentenaar, R., Eken, M., Homan-Weert, P. M., Saraci, E., D’Agostino, M., Velden, V. H. J. V. D., Sanders, M. A., Gay, F., Broijl, A., Moreau, P., Sonneveld, P., Zweegman, S., Mutis, T., Cupedo, T., Donk, N. W. C. J. V. D. (2025). The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy. Blood. https://doi.org/10.1182/blood.2024026455